Cumulative Incidence and Relative Risk of Infection in Patients With Multiple Myeloma Treated With Anti-CD38 Monoclonal Antibody-Based Regimens: A Systematic Review and Meta-analysis

BACKGROUND: Patients with multiple myeloma are at higher risk for infections due to disease pathogenesis and administered therapies. The purpose of this study was to estimate the risk for any grade and severe infections associated with the use of anti-CD38 monoclonal antibodies in patients with mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassilopoulos, Stephanos, Vassilopoulos, Athanasios, Kalligeros, Markos, Shehadeh, Fadi, Mylonakis, Eleftherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685179/
https://www.ncbi.nlm.nih.gov/pubmed/36438616
http://dx.doi.org/10.1093/ofid/ofac574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685179/
https://www.ncbi.nlm.nih.gov/pubmed/36438616
http://dx.doi.org/10.1093/ofid/ofac574

Ejemplares similares